glucagon has been researched along with wy 41747 in 3 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (wy 41747) | Trials (wy 41747) | Recent Studies (post-2010) (wy 41747) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimitriadis, G; Gerich, J | 1 |
| Dimitriadis, G; Gerich, J; Tessari, P | 1 |
| Gerich, J; Hall, L; Krom, B; Martin, C; Wallum, B | 1 |
3 other study(ies) available for glucagon and wy 41747
| Article | Year |
|---|---|
Effect of twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Glucagon; Humans; Injections, Subcutaneous; Insulin; Male; Somatostatin | 1985 |
Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucagon; Growth Hormone; Humans; Hyperglycemia; Insulin; Male; Somatostatin; Triglycerides; Xylose | 1983 |
Effect of a zinc phosphate suspension of a long-acting somatostatin analog on postprandial plasma glucose, triglyceride and glucagon concentrations in alloxan diabetic dogs.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Fats; Feces; Glucagon; Phosphates; Somatostatin; Suspensions; Triglycerides; Xylose; Zinc; Zinc Compounds | 1984 |